The New QEII Hospital is located in Welwyn Garden City and managed by East and North Hertfordshire NHS Trust.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Bayer
1
Cardiff and Vale University Health Board
1
Institute of Cancer Research, United Kingdom
1
Pfizer
1
Clinical Trials at Queen Elizabeth II Hospital
During the past decade, Queen Elizabeth II Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on
average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.
2020-01-30
2021-10-08
Completed
755
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Queen Elizabeth II Hospital" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Bayer" with 1 trials
sponsored, "Cardiff and Vale University Health Board" with 1 trials sponsored, "Institute of Cancer Research, United Kingdom" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth II Hospital"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Queen Elizabeth II Hospital
According to Clinical.Site data, the most researched conditions in "Queen Elizabeth II Hospital" are
"Atrial Fibrillation" (1 trials), "Atrial Fibrillation (AF)" (1 trials), "Breast Cancer" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Queen Elizabeth II Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Queen Elizabeth II Hospital
Most popular intervention types in "Queen Elizabeth II Hospital" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Aromatase Inhibitors" (1 trials) and "BAY2433334" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Queen Elizabeth II Hospital
The vast majority of trials in "Queen Elizabeth II Hospital" are
6 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Queen Elizabeth II Hospital
Currently, there are NaN active trials in "Queen Elizabeth II Hospital".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Queen Elizabeth II Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Queen Elizabeth II Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".